OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Nawaf A. Alsaif, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104345-104345
Closed Access | Times Cited: 26
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Nawaf A. Alsaif, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104345-104345
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies
Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105710-105710
Closed Access | Times Cited: 24
Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105710-105710
Closed Access | Times Cited: 24
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 610-610
Open Access | Times Cited: 12
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 610-610
Open Access | Times Cited: 12
Exploring of N-phthalimide-linked 1,2,3-triazole analogues with promising anti-SARS-CoV-2 activity: synthesis, biological screening, and molecular modelling studies
Ateyatallah Aljuhani, Mosa Alsehli, Mohamed A. Seleem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Ateyatallah Aljuhani, Mosa Alsehli, Mohamed A. Seleem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 4, pp. 407-480
Closed Access | Times Cited: 20
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 4, pp. 407-480
Closed Access | Times Cited: 20
Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
Ashwag S. Alanazi, Tebyan O. Mirgany, Nawaf A. Alsaif, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 989-997
Open Access | Times Cited: 10
Ashwag S. Alanazi, Tebyan O. Mirgany, Nawaf A. Alsaif, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 989-997
Open Access | Times Cited: 10
An Updated Overview on the Synthesis and Anticancer Evaluation of Quinazoline Derivatives
Jasneet Kaur, Sukhmeet Kaur, Amit Ȧnand, et al.
ChemistrySelect (2023) Vol. 8, Iss. 30
Open Access | Times Cited: 10
Jasneet Kaur, Sukhmeet Kaur, Amit Ȧnand, et al.
ChemistrySelect (2023) Vol. 8, Iss. 30
Open Access | Times Cited: 10
Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Nawaf A. Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1520-1538
Open Access | Times Cited: 24
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Nawaf A. Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1520-1538
Open Access | Times Cited: 24
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability
Jiaqi Zhou, Yuxing Zou, Yan Cai, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105453-105453
Closed Access | Times Cited: 17
Jiaqi Zhou, Yuxing Zou, Yan Cai, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105453-105453
Closed Access | Times Cited: 17
Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
Synthesis, antiproliferative and enzymatic inhibition activities of quinazolines incorporating benzenesulfonamide: Cell cycle analysis and molecular modeling study
Adel S. El‐Azab, Hamad M. Alkahtani, Nawaf A. Alsaif, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134928-134928
Closed Access | Times Cited: 6
Adel S. El‐Azab, Hamad M. Alkahtani, Nawaf A. Alsaif, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134928-134928
Closed Access | Times Cited: 6
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study
Salma Fares, Khalid B. Selim, Fatma E. Goda, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1487-1498
Open Access | Times Cited: 7
Salma Fares, Khalid B. Selim, Fatma E. Goda, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1487-1498
Open Access | Times Cited: 7
Design, synthesis, cytotoxicity evaluation and molecular docking studies of 1,4-naphthoquinone derivatives
Tian Qin, Yanyan Ma, Chang‐E Dong, et al.
Journal of Molecular Structure (2022) Vol. 1263, pp. 133067-133067
Closed Access | Times Cited: 5
Tian Qin, Yanyan Ma, Chang‐E Dong, et al.
Journal of Molecular Structure (2022) Vol. 1263, pp. 133067-133067
Closed Access | Times Cited: 5
Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors
Hamad M. Alkahtani, Amer Alhaj Zen, Ahmad J. Obaidullah, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 120-120
Open Access | Times Cited: 5
Hamad M. Alkahtani, Amer Alhaj Zen, Ahmad J. Obaidullah, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 120-120
Open Access | Times Cited: 5
Antibacterial evaluation of 2-(6-Chloro-2-p-tolylquinazolin-4-ylthio) acetonitrile against pathogenic bacterial isolates with special reference to biofilm formation inhibition and anti-adherence properties
Sultan Alasmari, Mohammed H. Makkawi, Irfan Ahmad, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103316-103316
Open Access
Sultan Alasmari, Mohammed H. Makkawi, Irfan Ahmad, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103316-103316
Open Access
Determination of the Interactions of a Schiff Base with Different Targets via Molecular Docking and Cytotoxic Activity Studies
Burçin Türkmenoğlu, İrem BAYAR, Zülbiye Kökbudak, et al.
Journal of the Indian Chemical Society (2024), pp. 101401-101401
Closed Access
Burçin Türkmenoğlu, İrem BAYAR, Zülbiye Kökbudak, et al.
Journal of the Indian Chemical Society (2024), pp. 101401-101401
Closed Access
Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access
The significance of quinazoline derivatives as potential multi-target anti-cancer agents: review article
Mostafa A. Mansour, Samar H. Abbas, Asma AboulMagd, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 1-17
Open Access | Times Cited: 1
Mostafa A. Mansour, Samar H. Abbas, Asma AboulMagd, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 1-17
Open Access | Times Cited: 1
